| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 22,500 | 23 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics, Inc. | 23 May 2023 | 1 | $0 | 4 | Director | 25 May 2023, 19:31 |
| FDMT | 4D Molecular Therapeutics, Inc. | 23 Sep 2022 | 1 | $0 | 4 | Director | 27 Sep 2022, 17:08 |
| FDMT | 4D Molecular Therapeutics, Inc. | 23 Sep 2022 | 0 | $0 | 3 | Director | 27 Sep 2022, 17:00 |